Chandra Bhagat Pharma Limited Share Price

Chandra Bhagat Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the business of marketing pharmaceutical critical care and health care products. The Company is focused on marketing pharmaceutical formulations and products in the domestic and international market through its own distribution network and sales under its own brand. It focuses on Injection - IV (Intravenous) and IM (Intramuscular), tablets and capsules supplied to hospitals and health care centers for critical diseases. The Company also deals in importing and supplying active pharmaceutical ingredients (API) and its intermediates. The Company also has its presence in the therapeutic categories for formulations such as anti-cancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, antifungal, antiviral, pediatrics, cardiology, nephrology, and neurology. It is also engaged in promoting and marketing of API in India.

Chandra Bhagat Pharma Limited Financial Highlights

• Revenue: Chandra Bhagat Pharma Limited reported revenue of ₹119.62 crore in FY26 vs ₹92.24 crore in FY25. It showed an increase of 29.68% on a yearly basis.
• Operating Profit: Chandra Bhagat Pharma Limited reported an operating profit of ₹4.11 crore in FY26 vs ₹1.17 crore in FY25. It showed an increase of 251.28% on a year-on-year basis.
• Net Profit: Chandra Bhagat Pharma Limited reported a net profit of ₹3.05 crore in FY26 vs ₹0.86 crore in FY25. It showed an increase of 254.65% on a yearly basis.